[Differences in the anti-arrhythmia effect of dalargin and beta-endorphin in severe myocardial ischemia during stimulation of the sensorimotor cortex].
Mikhaĭlova
S D
SD
Storozhakov
G I
GI
Kudinova
A V
AV
Semushkina
T M
TM
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D002415:Cats; D016308:Enkephalin, Leucine-2-Alanine / Q000031:analogs & derivatives* / Q000494:pharmacology; D005260:Female; D008297:Male; D009044:Motor Cortex / Q000502:physiology*; D017202:Myocardial Ischemia / Q000150:complications / Q000503:physiopathology*; D013003:Somatosensory Cortex / Q000502:physiology*; D017180:Tachycardia, Ventricular / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D014693:Ventricular Fibrillation / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D001615:beta-Endorphin / Q000494:pharmacology*
D000889:Anti-Arrhythmia Agents; D001615:beta-Endorphin; D016308:Enkephalin, Leucine-2-Alanine; C040996:enkephalin-Leu, Ala(2)-Arg(6)-